Who had a pre-excitation syndrome of the heart named after him and introduced a new use for the drug lidocaine?
Lown–Ganong–Levine syndrome Lown–Ganong–Levine syndrome (LGL) is a pre-excitation syndrome of the heart due to abnormal electrical communication between the atria and the ventricles. Once thought to involve an accessory conduction pathway, it is grouped with Wolff–Parkinson–White syndrome as an atrioventricular re-entrant tachycardia (AVRT). Individuals with LGL syndrome have a short PR interval with normal QRS complexes and paroxysms of clinically-significant tachycardia. The syndrome is named after Bernard Lown, William Francis Ganong, Jr., and Samuel A. Levine.
Adams–Stokes syndrome Stokes–Adams syndrome (alternative eponyms include "Adams–Stokes syndrome", "Gerbezius-Morgagni-Adams–Stokes syndrome" and "Gerbec-Morgagni-Adams–Stokes syndrome") is a periodic fainting spell in which there is a periodic onset and offset of blockage of heart due to disorder of heart rhythm that may last for seconds, hours, days, or even weeks before the conduction returns. Named after two Irish physicians, Robert Adams (1791–1875) and William Stokes (1804–1877), the first description of the syndrome was published in 1717 by the Carniolan physician of Slovene descent Marko Gerbec, which was 44 years after its publication quoted by Giovanni Battista Morgagni. It is characterised by decrease in cardiac output and loss of consciousness due to a transient arrhythmia. For example, bradycardia due to complete heart block.